Literature DB >> 21103304

Irreversible electroporation: a novel image-guided cancer therapy.

Edward W Lee1, Susan Thai, Stephen T Kee.   

Abstract

Irreversible electroporation (IRE) is a novel tumor ablation technique using a non-thermal energy to create innumerable permanent nanopores in the cell membrane to disrupt cellular homeostasis. This disruption of cellular homeostasis initiates apoptosis which leads to permanent cell death. In our translational research, we have demonstrated that IRE can be a safe, fast and powerful method of tumor treatment. In this review, we present an overview of IRE ablation including a brief history of IRE, advantages and disadvantages of IRE and clinical and research implications of IRE.

Entities:  

Keywords:  Apoptosis; Irreversible electroporation; Tumor treatment

Year:  2010        PMID: 21103304      PMCID: PMC2989557          DOI: 10.5009/gnl.2010.4.S1.S99

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


  26 in total

1.  Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect.

Authors:  David S K Lu; Steven S Raman; Darko J Vodopich; Michael Wang; James Sayre; Charles Lassman
Journal:  AJR Am J Roentgenol       Date:  2002-01       Impact factor: 3.959

2.  A novel nonthermal energy source for surgical epicardial atrial ablation: irreversible electroporation.

Authors:  Jacob Lavee; Gary Onik; Paul Mikus; Boris Rubinsky
Journal:  Heart Surg Forum       Date:  2007       Impact factor: 0.676

3.  Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation.

Authors:  Edward W Lee; Christopher T Loh; Stephen T Kee
Journal:  Technol Cancer Res Treat       Date:  2007-08

4.  Irreversible electroporation: implications for prostate ablation.

Authors:  Gary Onik; Paul Mikus; Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2007-08

5.  Irreversible electroporation in medicine.

Authors:  Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2007-08

6.  Preclinical analysis of irreversible electroporation on rat liver tissues using a microfabricated electroporator.

Authors:  Youn-Suk Choi; Hong-Bae Kim; Junho Chung; Hyung-Sik Kim; Jeong-Han Yi; Je-Kyun Park
Journal:  Tissue Eng Part C Methods       Date:  2010-04-06       Impact factor: 3.056

7.  Strength-duration curves for cardiac pacemaking and ventricular fibrillation.

Authors:  M Jones; L A Geddes
Journal:  Cardiovasc Res Cent Bull       Date:  1977 Apr-Jun

8.  Irreversible electroporation: a new challenge in "out of operating theater" anesthesia.

Authors:  Christine Ball; Kenneth R Thomson; Helen Kavnoudias
Journal:  Anesth Analg       Date:  2010-02-08       Impact factor: 5.108

9.  Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation.

Authors:  Edward W Lee; Christine Chen; Veronica E Prieto; Sarah M Dry; Christopher T Loh; Stephen T Kee
Journal:  Radiology       Date:  2010-05       Impact factor: 11.105

Review 10.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more
  45 in total

Review 1.  Ablation techniques for primary and metastatic liver tumors.

Authors:  Michael J Ryan; Jonathon Willatt; Bill S Majdalany; Ania Z Kielar; Suzanne Chong; Julie A Ruma; Amit Pandya
Journal:  World J Hepatol       Date:  2016-01-28

2.  Rapid dramatic alterations to the tumor microstructure in pancreatic cancer following irreversible electroporation ablation.

Authors:  Zhuoli Zhang; Weiguo Li; Daniel Procissi; Patrick Tyler; Reed A Omary; Andrew C Larson
Journal:  Nanomedicine (Lond)       Date:  2013-09-11       Impact factor: 5.307

3.  Irreversible electroporation for treatment of liver cancer.

Authors:  Govindarajan Narayanan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-05

Review 4.  Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?

Authors:  Camille L Stewart; Susanne Warner; Kaori Ito; Mustafa Raoof; Geena X Wu; Jonathan Kessler; Jae Y Kim; Yuman Fong
Journal:  Curr Probl Surg       Date:  2018-10-04       Impact factor: 1.909

5.  Preclinical and clinical evaluation of the liver tumor irreversible electroporation by magnetic resonance imaging.

Authors:  Matteo Figini; Xifu Wang; Tianchu Lyu; Zhanliang Su; Daniele Procissi; Vahid Yaghmai; Andrew C Larson; Zhuoli Zhang
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

6.  Recurrence patterns following irreversible electroporation for hepatic malignancies.

Authors:  Russell C Langan; Debra A Goldman; Michael I D'Angelica; Ronald P DeMatteo; Peter J Allen; Vinod P Balachandran; William R Jarnagin; T Peter Kingham
Journal:  J Surg Oncol       Date:  2017-05-11       Impact factor: 3.454

Review 7.  Regional hepatic therapies: an important component in the management of colorectal cancer liver metastases.

Authors:  Abdul Saied; Steven C Katz; N Joseph Espat
Journal:  Hepatobiliary Surg Nutr       Date:  2013-04       Impact factor: 7.293

Review 8.  Irreversible electroporation: evolution of a laboratory technique in interventional oncology.

Authors:  Amy R Deipolyi; Alexander Golberg; Martin L Yarmush; Ronald S Arellano; Rahmi Oklu
Journal:  Diagn Interv Radiol       Date:  2014 Mar-Apr       Impact factor: 2.630

Review 9.  [Ablative therapy of small renal masses].

Authors:  M C Kriegmair; N Wagener; S J Diehl; N Rathmann
Journal:  Urologe A       Date:  2018-03       Impact factor: 0.639

10.  Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.

Authors:  H J Scheffer; K Nielsen; A A J M van Tilborg; J M Vieveen; R A Bouwman; G Kazemier; H W M Niessen; S Meijer; C van Kuijk; M P van den Tol; M R Meijerink
Journal:  Eur Radiol       Date:  2014-06-18       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.